BridgeHead Software appoints David Moysen as Director of IT

Proven IT specialist will oversee global IT infrastructure roadmap and drive organisational performance

ASHTEAD, UK – 8 May 2019BridgeHead Software, a leader in healthcare data management, today announces the appointment of David Moysen as its new Director of IT. In his new role, Moysen will be responsible for defining and executing BridgeHead’s infrastructure roadmap and aligning IT strategy to the organisation’s needs. Based in the UK, he will oversee and manage global IT operations across BridgeHead’s Ashtead and Boston offices.

Moysen joins from the Human Fertilisation and Embryology Authority (HFEA) where he spent 14 years as the Head of IT, directing technology operations and managing the implementation of new systems and policies. Before his time at HFEA, Moysen held several senior IT positions at companies including Marketsource Europe and Sila; he also earned a BSc in electronic engineering from the University of Kent.

“We are very pleased to have David join our team – he has a wealth of experience in the provision of mission critical data services and his time spent at HFEA means he has gained a deep understanding of the IT challenges facing healthcare organisations,” said Simon Peters, Director of Finance and Administration at BridgeHead Software. “David is joining BridgeHead at an exciting time, as we’re seeing a heightened need for the consolidation, storage and protection of vital patient information. David’s experience and achievements will help us drive performance across the business.”

Commenting on his appointment, David Moysen added: “With an industry-wide drive in healthcare to create more efficient enterprise medical and administrative data management, BridgeHead is leading the way in providing clinicians with access to patient information when they need it, at the point of care. The company’s ecosystem of customers and partners enable healthcare organisations to improve the storage, security and management of electronic patient records. I am excited to join the company and help its highly-ambitious employees to innovate and seize the opportunities in this growing market.”

[ENDS]

About BridgeHead Software
Celebrating its 25th anniversary this year, BridgeHead Software is a leader in data and storage management dedicated entirely to the healthcare industry and is trusted by over 1,200 hospitals worldwide. Today, BridgeHead Software helps healthcare facilities overcome challenges stemming from rising data volumes and increasing storage costs while delivering peace of mind around how to consolidate, store, protect and share clinical, business and financial information.

BridgeHead’s Healthcare Data Management solutions are designed to work with any hospital’s chosen applications and storage hardware, regardless of vendor, providing greater choice, flexibility and control over the way data is managed, now and in the future. For more information, visit https://www.bridgeheadsoftware.com or follow on Twitter at @BridgeHeadHDM.

For more information
Visit http://www.bridgeheadsoftware.com
Follow the BridgeHead Software blog
Follow us on Twitter
Follow us on LinkedIn
Like BridgeHead Software on Facebook

BridgeHead Software Media Contacts:
UK and EMEA
Joanna Clark
Mantis PR
Mobile: + 44 7519 105 488
Email: joannaclark@mantispr.co.uk

Source: RealWire

user

Recent Posts

Bristol Myers Squibb Expands Health Equity Grant Initiatives to Improve Health Outcomes

Company Awards $1.8M in Grants to Eight Organizations in Brazil, India, Thailand and the United…

48 mins ago

Universal Recall Platform Alliance Launches to Keep Patients Safe

Industry initiative URPA broadens calls to improve speed, accuracy of recall communicationWEST HOLLYWOOD, CA /…

48 mins ago

Elicio Therapeutics Reports 2023 Financial Results and Provides Corporate Updates

ELI-002 2P clinical immunogenicity data were accepted for a poster presentation at the AACR Annual…

4 hours ago

Molecular Templates, Inc. Reports Fourth Quarter 2023 Financial Results and Business Update

AUSTIN, Texas, March 29, 2024 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or…

4 hours ago

KALA BIO Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

-- Advancing ongoing Phase 2b CHASE trial of KPI-012 for PCED; topline data targeted by…

4 hours ago

Galectin Therapeutics Reports 2023 Financial Results and Provides Business Update

NORCROSS, Ga., March 29, 2024 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading…

4 hours ago